Rising demand for precision medicine & groundbreaking innovations in RNA sequencing drive growth in oncology, drug discovery, & personalized therapies.

Following the lead of previous work on mRNA-based vaccines, therapies for spinal cord injuries and more, the method relies upon mineral-coated microparticles to deliver mRNA that encodes for ...

TikTok's ban in the US is fast approaching on January 19 unless the US Supreme Court decides to intervene, and many users could be seeking a new alternative to the app in a week's time.

For a long time now, it seems like the stock market has had a “theme of the year.” Clearly in 2024 it was AI, while 2023 was the year of recovery from 2022, which was a year of panic over a ...

What about an mRNA vaccine for H5N1? There isn't one yet, but several companies—including Moderna, Pfizer and GlaxoSmithKline (in collaboration with CureVac)—are working on such a shot.

Some social media users who fear the looming TikTok ban say they may pivot to Lemon8, a TikTok sister app with similar features—but Lemon8 was also developed by the Chinese company ByteDance ...

In this article, we are going to take a look at where Moderna Inc. (NASDAQ:MRNA) stands against other firms end 2024 stronger with impressive gains. A lackluster trading persisted throughout the ...

The field of plant photobiology has evolved rapidly over the past decade, expanding our understanding of how light influences every aspect of plant life, from gene expression to ecosystem interactions ...

It’s difficult to define what counts as alternative rock. However, the flip side of differentiating the two is that it allows us to spotlight more rock-adjacent artists and bands without having ...

Department of Bioengineering, University of Pennsylvania, Philadelphia, Pennsylvania 19104, United States Department of Bioengineering, University of Pennsylvania, Philadelphia, Pennsylvania 19104, ...

The mRNA cancer vaccine mRNA-4157, developed with Merck (MRK) might have the most promising upside with biopharma awaiting a key Phase 2 interim readout for the melanoma treatment in Q4 2025/H1 2026.